TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Bladder cancer Market, by Type
6.1 Introduction
6.2 Transitional Cell Carcinoma
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Invasive Bladder Cancer
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Superficial Bladder Cancer
6.4.1 Market Estimates & Forecast, 2020-2027
6.5 Adenocarcinomax
6.5.1 Market Estimates & Forecast, 2020-2027
6.6 Other rare types
Chapter 7. Global Bladder Cancer Market, by Treatment
7.1 Introduction
7.2 Chemotherapy
7.2.1 Market Estimates & Forecast, 2020-2027
7.2.2 Valstar (valrubicin)
7.2.2.1 Market Estimates & Forecast, 2020-2027
7.2.3 Javlor (vinflunine ditartrate),
7.2.3.1 Market Estimates & Forecast, 2020-2027
7.2.4 Mitomycin C
7.2.4.1 Market Estimates & Forecast, 2020-2027
7.2.5 Gemcitabine and cisplatin chemotherapy (GemCis)
7.2.5.1 Market Estimates & Forecast, 2020-2027
7.2.6 Others
7.3 Radiation Therapy
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 Immunotherapy
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 Radical Cystectomy
7.5.1 Market Estimates & Forecast, 2020-2027
7.6 Other
Chapter 8. Global Bladder Cancer Market, by Diagnosis
8.1 Introduction
8.2 Urine Lab Tests
8.2.1 Market Estimates & Forecast, 2020-2027
8.2.2 Urinalysis
8.2.2.1 Market Estimates & Forecast, 2020-2027
8.2.3 Urine Cytology
8.2.3.1 Market Estimates & Forecast, 2020-2027
8.2.4 Urine Culture
8.2.4.1 Market Estimates & Forecast, 2020-2027
8.2.5 Urine Tumor Marker Test
8.2.5.1 Market Estimates & Forecast, 2020-2027
8.3 Cystoscopy
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Biopsy
8.4.1 Market Estimates & Forecast, 2020-2027
8.4 Imaging Test
8.4.1 Market Estimates & Forecast, 2020-2027
8.4.2 Intravenous Pyelogram (IVP)
8.4.2.1 Market Estimates & Forecast, 2020-2027
8.4.3 Computed Tomography (CT) scan
8.4.3.1 Market Estimates & Forecast, 2020-2027
8.4.4 Magnetic Resonance Imaging (MRI) Scan
8.4.4.1 Market Estimates & Forecast, 2020-2027
8.4.5 Bladder Ultrasound
8.4.5.1 Market Estimates & Forecast, 2020-2027
8.5 Other
Chapter 9. Global Bladder Cancer Market, by End Users
9.1 Introduction
9.2 Hospital
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Clinic
9.3.1 Market Estimates & Forecast, 2020-2027
9.4 Cancer Care Centers
9.4.1 Market Estimates & Forecast, 2020-2027
9.5 Other
Chapter 10 Company Profiles
10.1 AstraZeneca plc.
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials
10.1.4 SWOT Analysis
10.2 Bristol-Myers Squibb Company
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Celgene Corporation.
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Eli Lilly and Company.
10.4.1 Company Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 F. Hoffmann-La Roche AG
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.6 GlaxoSmithKline plc.
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.7 Novartis International AG
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Pfizer Inc.
10.8.1 Company Overview
10.8.2 Product/Business Segment Overview
10.8.3 Financial Overview
10.8.4 Key Development
10.8.5 SWOT Analysis
10.9 Swastika international Co.
10.9.1 Company Overview
10.9.2 Product Overview
10.9.3 Financial overview
10.9.4 Key Developments
10.10 Stanley Black & Decker
10.10.1 Company Overview
10.10.2 Product Overview
10.10.3 Financial overview
10.10.4 Key Developments
10.11 Celgene Corporation.
10.11.1 Company Overview
10.11.2 Product Overview
10.11.3 Financial overview
10.11.4 Key Developments
10.12 Others
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s View Point
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Prediction of Pharmaceutical industry
Chapter 12 Appendix
LIST OF TABLES
Table 1 Bladder cancer Industry Synopsis, 2020-2027
Table 2 Bladder cancer Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Bladder cancer Market by Region, 2020-2027, (USD Million)
Table 4 Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 5 Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 6 Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 7 Bladder cancer Market by End Users, 2020-2027, (USD Million)
Table 8 North America Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 9 North America Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 10 North America Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 11 North America Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 12 US Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 13 US Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 14 US Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 15 US Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 16 Canada Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 17 Canada Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 18 Canada Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 19 Canada Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 20 South America Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 21 South America Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 22 South America Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 23 South America Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 24 Europe Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 25 Europe Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 26 Europe Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 27 Europe Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 28 Western Europe Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 29 Western Europe Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 30 Western Europe Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 31 Western Europe Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 32 Eastern Europe Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 33 Eastern Europe Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 34 Eastern Europe Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 35 Eastern Europe Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 36 Asia Pacific Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 37 Asia Pacific Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 38 Asia Pacific Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 39 Asia Pacific Bladder cancer Market by End User, 2020-2027, (USD Million)
Table 40 The Middle East & Africa Bladder cancer Market by Type, 2020-2027, (USD Million)
Table 41 The Middle East & Africa Bladder cancer Market by Treatment, 2020-2027, (USD Million)
Table 42 The Middle East & Africa Bladder cancer Market by Diagnosis, 2020-2027, (USD Million)
Table 43 The Middle East & Africa Bladder cancer Market by End User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Bladder cancer Market
Figure 3 Segmentation Market Dynamics for Bladder cancer Market
Figure 4 Global Bladder cancer Market Share, by Type 2020
Figure 5 Global Bladder cancer Market Share, by Treatment 2020
Figure 6 Global Bladder cancer Market Share, by Diagnosis 2020
Figure 7 Global Bladder cancer Market Share, by End-User 2020
Figure 8 Global Bladder cancer Market Share, by Region, 2020
Figure 9 Americas Bladder cancer Market Share, by Country, 2020
Figure 10 Europe Bladder cancer Market Share, by Country, 2020
Figure 11 Asia Pacific Bladder cancer Market Share, by Country, 2020
Figure 12 Middle East & Africa Bladder cancer Market Share, by Country, 2020
Figure 13 Global Bladder cancer Market: Company Share Analysis, 2020 (%)
Figure 14 AstraZeneca plc: Key Financials
Figure 15 AstraZeneca plc: Segmental Revenue
Figure 16 AstraZeneca plc: Geographical Revenue
Figure 17 Bristol-Myers Squibb Company: Key Financials
Figure 18 Bristol-Myers Squibb Company: Segmental Revenue
Figure 19 Bristol-Myers Squibb Company: Geographical Revenue
Figure 20 Celgene Corporation.: Key Financials
Figure 21 Celgene Corporation.: Segmental Revenue
Figure 22 Celgene Corporation.: Geographical Revenue
Figure 23 Eli Lilly and Company: Key Financials
Figure 24 Eli Lilly and Company: Segmental Revenue
Figure 25 Eli Lilly and Company: Geographical Revenue
Figure 26 F. Hoffmann-La Roche AG: Key Financials
Figure 27 F. Hoffmann-La Roche AG: Segmental Revenue
Figure 28 F. Hoffmann-La Roche AG: Geographical Revenue
Figure 29 GlaxoSmithKline plc: Key Financials
Figure 30 GlaxoSmithKline plc: Segmental Revenue
Figure 31 GlaxoSmithKline plc: Geographical Revenue
Figure 32 Novartis International AG: Key Financials
Figure 33 Novartis International AG: Segmental Revenue
Figure 34 Novartis International AG: Geographical Revenue
Figure 35 Pfizer Inc.: Key Financials
Figure 36 Pfizer Inc.: Segmental Revenue
Figure 37 Pfizer Inc.: Geographical Revenue
